(Q46007698)

18 December 2017

title

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. (English)

1 reference

18 December 2017

experimental autoimmune encephalomyelitis

main subject

0 references

1 reference

Francisco Sánchez-Madrid

4

1 reference

18 December 2017

author name string

Yednock TA

1

1 reference

18 December 2017

Cannon C

2

1 reference

18 December 2017

Fritz LC

3

1 reference

18 December 2017

Steinman L

5

1 reference

18 December 2017

Karin N

6

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 March 1992

1 reference

18 December 2017

published in

Nature

1 reference

18 December 2017

volume

356

1 reference

18 December 2017

page(s)

63-66

1 reference

18 December 2017

issue

6364

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1038/356063a0

exact match

0 references

cites work

Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis

1 reference

7 January 2021

Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse.

1 reference

7 January 2021

The T lymphocyte in experimental allergic encephalomyelitis

1 reference

7 January 2021

The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis

1 reference

7 January 2021

T-lymphocyte entry into the central nervous system

1 reference

7 January 2021

Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules

1 reference

7 January 2021

Integrins: a family of cell surface receptors

1 reference

7 January 2021

VLA proteins in the integrin family: structures, functions, and their role on leukocytes

1 reference

7 January 2021

VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

1 reference

7 January 2021

Identification of surface proteins mediating adherence of CD11/CD18-deficient lymphoblastoid cells to cultured human endothelium

1 reference

7 January 2021

Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lymphocytes. A CD11/CD18-independent adhesion mechanism

1 reference

7 January 2021

A cell-surface molecule involved in organ-specific homing of lymphocytes

1 reference

7 January 2021

Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells

1 reference

7 January 2021

Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types

1 reference

7 January 2021

Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins.

1 reference

7 January 2021

Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation

1 reference

7 January 2021

Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis.

1 reference

7 January 2021

Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system

1 reference

7 January 2021

Two integrin-binding peptides abrogate T cell-mediated immune responses in vivo

1 reference

7 January 2021

Vascular cell adhesion molecule 1 induces T-cell antigen receptor-dependent activation of CD4+T lymphocytes

1 reference

7 January 2021

VLA-4 mediates CD3-dependent CD4+ T cell activation via the CS1 alternatively spliced domain of fibronectin

1 reference

7 January 2021

Receptors involved in lymphocyte homing: relationship between a carbohydrate-binding receptor and the MEL-14 antigen

1 reference

7 January 2021

Identifiers

DOI

10.1038/356063A0

1 reference

18 December 2017

Dimensions Publication ID

0 references

1 reference

18 December 2017